APA

Herdman M., Kerr C., Pavesi M., Garside J., Lloyd A., Cubi-Molla P. & Devlin N. (2020). Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. : Journal of patient-reported outcomes.

Chicago

Herdman Michael, Kerr Cicely, Pavesi Marco, Garside Jamie, Lloyd Andrew, Cubi-Molla Patricia and Devlin Nancy. 2020. Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. : Journal of patient-reported outcomes.

Harvard

Herdman M., Kerr C., Pavesi M., Garside J., Lloyd A., Cubi-Molla P. and Devlin N. (2020). Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. : Journal of patient-reported outcomes.

MLA

Herdman Michael, Kerr Cicely, Pavesi Marco, Garside Jamie, Lloyd Andrew, Cubi-Molla Patricia and Devlin Nancy. Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. : Journal of patient-reported outcomes. 2020.